About last months September & October 2026

Conversations that make a difference…

If we had to sum up the start of the 2026 season in one word, it would be conversations! Not the ones that offer reassurance, but the ones that put slides to the test of reality, bring investors and entrepreneurs face to face, and bridge worlds that don’t speak the same language.

It’s also the start of a new chapter under a new identity: LallianSe, Catalyst for Action(s). Every conversation we’ve been part of over the past two months illustrates this mission: LallianSe creates the conditions for the right conversation to happen, at the right time, between the right people.

#SHEDLIGHT

Daring to have uncomfortable conversations

#MoneyQuest season episode #1 : ERROR 404 When the equity story doesn’t go as planned !

To kick off this second season, we went where things get a little less comfortable… On September 28, Julie Rachline, CEO of LallianSe and former CEO of BrainTale, shared her experience with Eric Garnier, President of Angels Santé, former investor in BrainTale and former member of its board. The discussion explored how an investment thesis evolves when viewed by an investor and a former CEO, what happens when reality forces a pivot, and how to navigate the end of a journey.

Equity Story: ERROR 404! The thesis didn’t work… Failure or experience?

No ready-made answers, just an open space for debate and collective learning.

MoneyQuest Season 2, Episode #2: When the financial roadmap goes off track, can you bounce back?

The conversation continues on October 23. Alongside Jérémy Ballet, CFO and Operating Partner at Alkyon Group, we explored what happens when financial roadmaps go off course: a fundraising round that drags on, an unsuitable capital structure, faster-than-expected growth, or shareholders no longer speaking the same language.

A failed roadmap is rarely an isolated accident. More often, it reveals a deeper misalignment between strategic vision and individual interests. Does it condemn the company to failure, or can it become a turning point?

#Conversations: LallianSe’s conversation starters

Because social media should be a place for interaction and debate, rather than a succession of success stories and top-down certainties, we’re trying something new to open up the conversation with our community.

What really causes a project to fail? Is a good idea enough to make a good project? And what about human capital? Perhaps the right question is no longer “Do we have the talent to innovate?” but rather “Are we truly creating the conditions for innovation?” Are the right people those with the most impressive CVs, or those who also know how to listen and challenge their own assumptions?

These open calls are an invitation to challenge established beliefs and put our own questions and doubts into words. An initiative that builds on LallianSe’s DNA.

Two calls are already live — discover them in our dedicated article here.

#TRANSFORM

Equipping, translating, bringing people together

Equity story: how do you turn an ambition into a compelling narrative?

Together with Medicen Paris Region and PariSanté Campus, Julie Rachline led a workshop on September 30 as part of a three-session series (September 8, September 30 and October 15) dedicated to fundraising preparation. Alongside ICOSA, Inserm Transfert and DNA Finance, the goal was to bring together the expertise HealthTech founders need, at the right time.

Three key takeaways from the workshop:

  • Make people want to be part of what comes next;
  • Apply the KISS principle: keep it simple, but not simplistic;
  • Be able to explain your project in one minute, without jargon;

Some participants even took on the 1-minute challenge.

Do you speak “LallianSe”? The art of creating a common language

A physician, an entrepreneur, a hospital executive and an investor don’t speak the same language. Yet healthcare innovation can only become reality when they understand one another. This is what we’ve been working on since 2017, drawing on seven years of immersion in the hospital environment at Pitié-Salpêtrière, from the creation of ASIIA to the BrainTale project.

We found the same dynamic at the “From Hospital to Start-up” event at GHU Sorbonne Université, where Julie Rachline moderated a panel featuring four clinicians who are also serial entrepreneurs: Pierre Mozer, Rachel Lévy, Harry Sokol and Louis Puybasset. Our role: translating the challenges of one world into terms another can understand.

#ACTION(S)

Facing the realities of the market

#BIG2026 — Can an innovation be excellent… and never get ordered?

On October 8, at the Accor Arena, alongside La French Care and Bpifrance’s Deeptech team, we moderated a panel around a simple question: how can we create solvent demand to accelerate health deeptech? Joining the discussion were Noa Bach (AP-HP, Paris Public Hospital System), Peggy Rematier (Bpifrance), Julie Rachline (LallianSe — Catalyst for Action(s) and former CEO of BrainTale — yes, wearing both hats!), Louis Potel (Resah) and Hicham Chehade (OPTACARE).

The takeaway: between a relevant solution and its first purchase order lie several hurdles — evidence of value, an available budget, a purchasing process, a contractual vehicle and a manufacturer that is still in business and able to invoice. Market access is an integral part of the equity story. It cannot be an afterthought once regulatory approvals have been secured. A major challenge for our healthcare system… and for innovation!

World M&A Alliance: Healthcare in Europe — opportunities for M&A? ?

At the invitation of Inspirit Partners on behalf of the World M&A Alliance, Julie Rachline moderated a discussion bringing together Grégoire Chauvière Le Drian from the European Investment Bank (EIB), Loïc Gonnet, Head of M&A at Sanofi, Benoit Varichon, Partner at ARCHIMED, and Pascal Raidron, Founder of EIGHT ADVISORY.

Their message was clear: a deal must be anticipated and built around people, with a thorough understanding of local dynamics. In healthcare, transactions cannot be considered independently of the ecosystems in which they take place.

Eurasanté x LallianSe: six years of partnership

As partners of BioFIT and MedFIT, we’ve supported these events for six years. They bring together more than 2,000 participants from 35 countries, 200 exhibitors and over 100 international speakers. An ideal setting for us to play our role as a catalyst: building bridges and sparking connections.

Partner benefit: enjoy 20% off your full pass. Get in touch to take advantage of the offer.

World with Women, October 13: When women stop, the world stops (or almost…)

To shine a light on what still goes unseen, the LallianSe team chose to step out of the spotlight for a day. A first step, but not the end of the journey: the real challenge is to contribute collectively, day in and day out. And thanks to Emmanuelle Quilès for bringing us into the loop!

#LOOKAHEAD

Building what comes next, together

MedTech World Malta 2026: the French delegation is on board

In November, we’re bringing back our French delegation initiative at MedTech World in Malta, taking it a step further and opening up new perspectives. LallianSe is bringing together a French delegation of more than 15 medtech stakeholders — investors and entrepreneurs — for a private session, a workshop on exit strategies and an investor panel.

Among the first participants to join us: Eric Garnier (Angels Santé); Sophie Brac de la Perrière (Healshape); Marielle Mailhes (Bpifrance); Fabrice Paublant (ORIXHA) — and more names to discover.

Our shared goal: create meaningful conversations between investors and CEOs, build bridges across Europe and anticipate exit opportunities. Will you be joining us? It’s a chance to connect in a relaxed, authentic atmosphere!

Enjoy a €150 discount with code MTWM_Lallianse150, and let us know if you’ll be there so we can meet up.

A collective manifesto: the wishes keep coming in

For the past two years, we’ve replaced individual New Year’s wishes with a shared wish box, bringing together contributions to create a collective manifesto. Thank you to Aude Nyadanu (Lowpital and NoviSano), Philippe Mendels-Flandre, AUSTRAL Dx, Karine Lignel, Oncodesign Precision Medicine — OPM and Patrick Errard for contributing. And even outside the New Year’s season — although it’s approaching fast — we’d love to hear your wishes. Share yours here: submit your wish.

#PERSPECTIVES

In a nutshell, these two months have reinforced our conviction: a good idea is not enough, and neither is a good conversation unless it translates into action(s).

We’ve shed light on failure and pivots without filters, equipped founders with practical tools, translated between worlds, put innovation to the test of market realities and M&A dynamics, and started preparing for what’s next in Malta and beyond.

What comes next? Staying true to our DNA: aligning vision, economic realities and stakeholders, one conversation at a time — or not!

To be continued

Views: 5